{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:15:28Z","timestamp":1787318128224,"version":"build-2736575974"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T00:00:00Z","timestamp":1703116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T00:00:00Z","timestamp":1703116800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-023-05513-0","type":"journal-article","created":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T12:02:25Z","timestamp":1703160145000},"page":"1219-1232","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Clinical characteristics, disease trajectories and management of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome: a systematic review"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6276-137X","authenticated-orcid":false,"given":"Koushan","family":"Kouranloo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6858-4338","authenticated-orcid":false,"given":"Mrinalini","family":"Dey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2900-7690","authenticated-orcid":false,"given":"Jude","family":"Almutawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2331-7284","authenticated-orcid":false,"given":"Nikki","family":"Myall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3849-614X","authenticated-orcid":false,"given":"Arvind","family":"Nune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,21]]},"reference":[{"key":"5513_CR1","doi-asserted-by":"crossref","unstructured":"Grayson PC, Patel BA, Young NS (2021) VEXAS syndrome. Blood [Internet]. 2021 Jul 1 [cited 2023 Jul 8];137(26):3591\u20134. https:\/\/pubmed.ncbi.nlm.nih.gov\/33971000\/. Accessed 8 July 2023","DOI":"10.1182\/blood.2021011455"},{"issue":"27","key":"5513_CR2","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1056\/NEJMoa2026834","volume":"383","author":"DB Beck","year":"2020","unstructured":"Beck DB, Ferrada MA, Sikora KA, Ombrello AK, Collins JC, Pei W et al (2020) Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease. N Engl J Med [Internet]. 383(27):2628\u20132638. https:\/\/doi.org\/10.1056\/NEJMoa2026834","journal-title":"N Engl J Med [Internet]."},{"issue":"27","key":"5513_CR3","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1056\/NEJMe2030754","volume":"383","author":"E Levy-Lahad","year":"2020","unstructured":"Levy-Lahad E, King MC (2020) Hiding in plain sight\u2014somatic mutation in human disease. N Engl J Med [Internet]. 383(27):2680\u20132682. https:\/\/doi.org\/10.1056\/NEJMe2030754","journal-title":"N Engl J Med [Internet]."},{"key":"5513_CR4","doi-asserted-by":"crossref","unstructured":"Ruffer N, Krusche M (2023) VEXAS syndrome: a diagnostic puzzle. RMD Open [Internet]. 2023 Aug 1 [cited 2023 Aug 13];9(3):e003332. https:\/\/rmdopen.bmj.com\/content\/9\/3\/e003332","DOI":"10.1136\/rmdopen-2023-003332"},{"key":"5513_CR5","doi-asserted-by":"crossref","unstructured":"Beck DB, Bodian DL, Shah V, Mirshahi UL, Kim J, Ding Y, et al (2023) Estimated prevalence and clinical manifestations of UBA1 variants associated with VEXAS syndrome in a clinical population. JAMA [Internet]. 2023 Jan 24 [cited 2023 Aug 13];329(4):318\u201324. https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2800661","DOI":"10.1001\/jama.2022.24836"},{"key":"5513_CR6","doi-asserted-by":"crossref","unstructured":"Beck DB, Bodian DL, Shah V, Mirshahi UL, Kim J, Ding Y, et al (2023) Estimated prevalence and clinical manifestations of UBA1 variants associated with VEXAS syndrome in a clinical population. JAMA [Internet]. 2023 Jan 24 [cited 2023 Aug 23];329(4):318\u201324. https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2800661","DOI":"10.1001\/jama.2022.24836"},{"key":"5513_CR7","doi-asserted-by":"crossref","unstructured":"Ferrada MA, Sikora KA, Luo Y, Wells K V., Patel B, Groarke EM, et al (2021) Somatic mutations in UBA1 define a distinct subset of relapsing polychondritis patients with VEXAS. Arthritis Rheumatol [Internet]. 2021 Oct 1 [cited 2023 Aug 23];73(10):1886\u201395. https:\/\/pubmed.ncbi.nlm.nih.gov\/33779074\/","DOI":"10.1002\/art.41743"},{"key":"5513_CR8","unstructured":"Beck DB, Ferrada MA, Sikora KA, Ombrello AK, Collins JC, Pei W, et al (2020) Somatic MUtations in UBA1 and severe adult-onset autoinflammatory disease. N Engl J Med [Internet]. 2020 Dec 31 [cited 2023 Aug 23];383(27):2628\u201338. https:\/\/pubmed.ncbi.nlm.nih.gov\/33108101\/"},{"key":"5513_CR9","doi-asserted-by":"crossref","unstructured":"Ruffer N, Krusche M (2023) VEXAS syndrome: a diagnostic puzzle. RMD Open [Internet]. 2023 Aug 1 [cited 2023 Aug 23];9(3):e003332. https:\/\/rmdopen.bmj.com\/content\/9\/3\/e003332","DOI":"10.1136\/rmdopen-2023-003332"},{"key":"5513_CR10","doi-asserted-by":"crossref","unstructured":"Oganesyan A, Jachiet V, Chasset F, Hirsch P, Hage-Sleiman M, Fabiani B, et al (2021) VEXAS syndrome: still expanding the clinical phenotype. Rheumatology (Oxford) [Internet]. 2021 Sep 1 [cited 2023 Aug 13];60(9):E321\u20133. https:\/\/pubmed.ncbi.nlm.nih.gov\/33693570\/","DOI":"10.1093\/rheumatology\/keab225"},{"key":"5513_CR11","doi-asserted-by":"crossref","unstructured":"Nguyen JK, Routledge D, van Der Weyden C, Blombery P, Angel CM, Johnson D, et al (2022) VEXAS syndrome: a dermatological perspective. Australas J Dermatol [Internet]. 2022 Nov 1 [cited 2023 Aug 23];63(4):488\u201392. https:\/\/pubmed.ncbi.nlm.nih.gov\/36197697\/","DOI":"10.1111\/ajd.13932"},{"issue":"7","key":"5513_CR12","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1111\/ijd.16635","volume":"62","author":"AS Hines","year":"2023","unstructured":"Hines AS, Mohandesi NA, Lehman JS, Koster MJ, Cantwell HM, Alavi A et al (2023) Cutaneous involvement in VEXAS syndrome: clinical and histopathologic findings. Int J Dermatol [Internet] 62(7):938\u2013945. https:\/\/doi.org\/10.1111\/ijd.16635","journal-title":"Int J Dermatol [Internet]"},{"key":"5513_CR13","doi-asserted-by":"crossref","unstructured":"Kouranloo K, Ashley A, Zhao SS, Dey M (2023) Pulmonary manifestations in VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome: a systematic review. Rheumatol Int [Internet]. 2023 Jun 1 [cited 2023 Aug 23];43(6):1023\u201332. https:\/\/pubmed.ncbi.nlm.nih.gov\/36617363\/","DOI":"10.1007\/s00296-022-05266-2"},{"key":"5513_CR14","doi-asserted-by":"crossref","unstructured":"Casal Moura M, Baqir M, Tandon YK, Samec MJ, Hines AS, Reichard KK, et al (2023) Pulmonary manifestations in VEXAS syndrome. Respir Med [Internet]. 2023 Jul 1 [cited 2023 Aug 23];213. https:\/\/pubmed.ncbi.nlm.nih.gov\/37062498\/","DOI":"10.1016\/j.rmed.2023.107245"},{"issue":"26","key":"5513_CR15","first-page":"3591","volume":"137","author":"PC Grayson","year":"2021","unstructured":"Grayson PC, Patel BA, Young NS (2021) VEXAS syndrome. Blood [Internet]. 137(26):3591","journal-title":"Blood [Internet]."},{"key":"5513_CR16","doi-asserted-by":"crossref","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ [Internet]. 2021 Mar 29 [cited 2023 Oct 6];372. https:\/\/www.bmj.com\/content\/372\/bmj.n71","DOI":"10.1136\/bmj.n71"},{"key":"5513_CR17","unstructured":"PROSPERO [Internet]. [cited 2023 Aug 6]. https:\/\/www.crd.york.ac.uk\/prospero\/#myprospero"},{"key":"5513_CR18","doi-asserted-by":"crossref","unstructured":"Yildirim F, Erdogan M, Yalcin Mutlu M, Akkuzu G, Ozgur DS, Karaalioglu B, et al (2023) VEXAS syndrome with severe multisystem involvement: Rapid recovery after splenectomy. Int J Rheum Dis [Internet]. 26(3):559\u201362. https:\/\/authproxy.bma.org.uk\/process\/redirects?url=https:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=medl&AN=36544349","DOI":"10.1111\/1756-185X.14540"},{"issue":"5","key":"5513_CR19","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1111\/bjh.18488","volume":"199","author":"A Al-Hakim","year":"2022","unstructured":"Al-Hakim A, Poulter JA, Mahmoud D, Rose AMS, Elcombe S, Lachmann H et al (2022) Allogeneic haematopoietic stem cell transplantation for VEXAS syndrome: UK experience. Br J Haematol [Internet] 199(5):777\u2013781. https:\/\/doi.org\/10.1111\/bjh.18488","journal-title":"Br J Haematol [Internet]"},{"key":"5513_CR20","doi-asserted-by":"crossref","unstructured":"Koster MJ, Kourelis T, Reichard KK, Kermani TA, Beck DB, Cardona DO, et al (2021) Clinical heterogeneity of the VEXAS syndrome: a case series. Mayo Clin Proc [Internet]. 96(10):2653\u20139. https:\/\/authproxy.bma.org.uk\/process\/redirects?url=https:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med20&AN=34489099","DOI":"10.1016\/j.mayocp.2021.06.006"},{"key":"5513_CR21","doi-asserted-by":"crossref","unstructured":"Stiburkova B, Pavelcova K, Belickova M, Magaziner SJ, Collins JC, Werner A, et al (2023) Novel somatic UBA1 variant in a patient with VEXAS syndrome. Arthritis Rheumatol [Internet]. 10:10. https:\/\/authproxy.bma.org.uk\/process\/redirects?url=https:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=medp&AN=36762418","DOI":"10.1002\/art.42471"},{"key":"5513_CR22","doi-asserted-by":"crossref","unstructured":"Stubbins RJ, McGinnis E, Johal B, Chen LY, Wilson L, Cardona DO, et al (2022) VEXAS syndrome in a female patient with constitutional 45,X (Turner syndrome). Haematologica [Internet]. 2022;107(4):1011\u20133. https:\/\/authproxy.bma.org.uk\/process\/redirects?url=https:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med21&AN=34911285","DOI":"10.3324\/haematol.2021.280238"},{"issue":"9\u201310","key":"5513_CR23","doi-asserted-by":"publisher","first-page":"327","DOI":"10.14740\/jmc4127","volume":"14","author":"H Pozdniakova","year":"2023","unstructured":"Pozdniakova H, Vedire A, Kadakia A, Imburgio S, Bajwa R, Gupta V et al (2023) A double hit to ubiquitination leading to a new diagnosis of VEXAS syndrome. J Med Cases Internet. 14(9\u201310):327","journal-title":"J Med Cases Internet."},{"key":"5513_CR24","unstructured":"Mascaro JM, Rodriguez-Pinto I, Poza G, Mensa-Vilaro A, Fernandez-Martin J, Caminal-Montero L, et al (2023) Spanish cohort of VEXAS syndrome: clinical manifestations, outcome of treatments and novel evidences about UBA1 mosaicism. Ann Rheum Dis [Internet]. 2023 [cited 2023 Oct 30]; https:\/\/pubmed.ncbi.nlm.nih.gov\/37666646\/"},{"key":"5513_CR25","doi-asserted-by":"crossref","unstructured":"Casal Moura M, Baqir M, Tandon YK, Samec MJ, Hines AS, Reichard KK, et al (2023) Pulmonary manifestations in VEXAS syndrome. Respir Med [Internet]. 2023 Jul 1 [cited 2023 Aug 13];213. https:\/\/pubmed.ncbi.nlm.nih.gov\/37062498\/","DOI":"10.1016\/j.rmed.2023.107245"},{"issue":"26","key":"5513_CR26","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.1182\/blood.2020010177","volume":"137","author":"E Bourbon","year":"2021","unstructured":"Bourbon E, Heiblig M, Gerfaud Valentin M, Barba T, Durel CA, Lega JC et al (2021) Therapeutic options in VEXAS syndrome: insights from a retrospective series. Blood [Internet] 137(26):3682\u20133684. https:\/\/doi.org\/10.1182\/blood.2020010177","journal-title":"Blood [Internet]"},{"key":"5513_CR27","doi-asserted-by":"crossref","unstructured":"Ferrada MA, Sikora KA, Luo Y, Wells K V, Patel B, Groarke EM, et al (2021) Somatic mutations in UBA1 define a distinct subset of relapsing polychondritis patients with VEXAS. Arthritis Rheumatol [Internet]. 73(10):1886\u201395. Available from: https:\/\/authproxy.bma.org.uk\/process\/redirects?url=https:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med19&AN=33779074","DOI":"10.1002\/art.41743"},{"key":"5513_CR28","doi-asserted-by":"crossref","unstructured":"Khitri MY, Guedon AF, Georgin-Lavialle S, Terrier B, Saadoun D, Seguier J, et al (2022) Comparison between idiopathic and VEXAS-relapsing polychondritis: analysis of a French case series of 95 patients. RMD Open [Internet] 2022 Jul 1 [cited 2023 Aug 13];8(2):e002255. https:\/\/rmdopen.bmj.com\/content\/8\/2\/e002255","DOI":"10.1136\/rmdopen-2022-002255"},{"key":"5513_CR29","doi-asserted-by":"crossref","unstructured":"Matsumoto H, Asano T, Tsuchida N, Maeda A, Yoshida S, Yokose K, et al (2022) Behcet\u2019s disease with a somatic UBA1 variant: expanding spectrum of autoinflammatory phenotypes of VEXAS syndrome. Clin Immunol [Internet]. 2022;238:108996. https:\/\/authproxy.bma.org.uk\/process\/redirects?url=https:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med21&AN=35398520","DOI":"10.1016\/j.clim.2022.108996"},{"key":"5513_CR30","unstructured":"Midtvedt O, Stray-Pedersen A, Andersson H, Gunnarsson R, Tveten K, Ali MM, et al (2022) A man in his sixties with chondritis and bone marrow failure. Tidsskrift for Den Norske Laegeforening [Internet]. 142(4):01. https:\/\/authproxy.bma.org.uk\/process\/redirects?url=https:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med21&AN=35239266"},{"key":"5513_CR31","doi-asserted-by":"crossref","unstructured":"Muratore F, Marvisi C, Castrignano P, Nicoli D, Farnetti E, Bonanno O, et al (2022) VEXAS syndrome: a case series from a single-center cohort of Italian patients with vasculitis. Arthritis Rheumatol [Internet] 74(4):665\u201370. https:\/\/authproxy.bma.org.uk\/process\/redirects?url=https:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med21&AN=34611997","DOI":"10.1002\/art.41992"},{"key":"5513_CR32","doi-asserted-by":"crossref","unstructured":"Obiorah IE, Patel BA, Groarke EM, Wang W, Trick M, Ombrello AK, et al (2021) Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1. Blood Adv [Internet]. 5(16):3203\u201315. https:\/\/authproxy.bma.org.uk\/process\/redirects?url=https:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med20&AN=34427584","DOI":"10.1182\/bloodadvances.2021004976"},{"key":"5513_CR33","doi-asserted-by":"crossref","unstructured":"Rasch MNB, Szabados F, Jensen JMB, Nielsen KO, Hauge EM, Troldborg A (2022) Patients with VEXAS diagnosed in a Danish tertiary rheumatology setting have highly elevated inflammatory markers, macrocytic anaemia and negative autoimmune biomarkers. RMD Open [Internet] 8. https:\/\/authproxy.bma.org.uk\/process\/redirects?url=https:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed23&AN=2020239150","DOI":"10.1136\/rmdopen-2022-002492"},{"key":"5513_CR34","doi-asserted-by":"crossref","unstructured":"van der Made CI, Potjewijd J, Hoogstins A, Willems HPJ, Kwakernaak AJ, de Sevaux RGL, et al (2022) Adult-onset autoinflammation caused by somatic mutations in UBA1: A Dutch case series of patients with VEXAS. J Allergy Clin Immunol [Internet]. 149(1):432\u2013439.e4. https:\/\/authproxy.bma.org.uk\/process\/redirects?url=https:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med21&AN=34048852","DOI":"10.1016\/j.jaci.2021.05.014"},{"key":"5513_CR35","doi-asserted-by":"crossref","unstructured":"Casal Moura M, Baqir M, Tandon YK, Samec MJ, Hines AS, Reichard KK, et al (2023) Pulmonary manifestations in VEXAS syndrome. Respir Med [Internet]. 2023 Jul 1 [cited 2023 Oct 30];213. https:\/\/pubmed.ncbi.nlm.nih.gov\/37062498\/","DOI":"10.1016\/j.rmed.2023.107245"},{"key":"5513_CR36","unstructured":"Pinto FR, Lamas A, Oliveira DG, Oliveira ME, Faria R (2023) VEXAS syndrome: a call for diagnostic awareness based on a case series of seven patients. Acta Med Port [Internet]. 2023 May 1 [cited 2023 Oct 30];36(5):379\u201380. https:\/\/pubmed.ncbi.nlm.nih.gov\/37071935\/"},{"key":"5513_CR37","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead245","author":"AS Hines","year":"2023","unstructured":"Hines AS, Koster MJ, Bock AR, Go RS, Warrington KJ, Olteanu H et al (2023) Targeted testing of bone marrow specimens with cytoplasmic vacuolization to identify previously undiagnosed cases of VEXAS syndrome. Rheumatology. https:\/\/doi.org\/10.1093\/rheumatology\/kead245","journal-title":"Rheumatology"},{"key":"5513_CR38","unstructured":"Salehi T, Callisto A, Beecher MB, Hissaria P (2023) Tofacitinib as a biologic response modifier in VEXAS syndrome: a case series. Int J Rheum Dis [Internet]. 2023 [cited 2023 Oct 30]; https:\/\/pubmed.ncbi.nlm.nih.gov\/37337622\/"},{"issue":"6","key":"5513_CR39","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s00296-022-05266-2","volume":"43","author":"K Kouranloo","year":"2023","unstructured":"Kouranloo K, Ashley A, Zhao SS, Dey M (2023) Pulmonary manifestations in VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome: a systematic review. Rheumatol Int [Internet] 43(6):1023\u20131032. https:\/\/doi.org\/10.1007\/s00296-022-05266-2","journal-title":"Rheumatol Int [Internet]"},{"key":"5513_CR40","doi-asserted-by":"crossref","unstructured":"Stiburkova B, Pavelcova K, Belickova M, Magaziner SJ, Collins JC, Werner A, et al (2023) Novel somatic UBA1 variant in a patient with VEXAS syndrome. Arthritis Rheumatol [Internet]. 2023 Jul 1 [cited 2023 Oct 30];75(7):1285\u201390. https:\/\/pubmed.ncbi.nlm.nih.gov\/36762418\/","DOI":"10.1002\/art.42471"},{"key":"5513_CR41","doi-asserted-by":"crossref","unstructured":"Oo TM, Koay JTJ, Lee SF, Lee SMS, Lim XR, Fan BE (2022) Thrombosis in VEXAS syndrome. J Thromb Thrombolysis [Internet]. 53(4):965\u201370. https:\/\/authproxy.bma.org.uk\/process\/redirects?url=https:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med21&AN=34817788","DOI":"10.1007\/s11239-021-02608-y"},{"key":"5513_CR42","doi-asserted-by":"crossref","unstructured":"Nguyen JK, Routledge D, van Der Weyden C, Blombery P, Angel CM, Johnson D, et al (2022) VEXAS syndrome: a dermatological perspective. Australas J Dermatol [Internet]. 63(4):488\u201392. https:\/\/authproxy.bma.org.uk\/process\/redirects?url=https:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med22&AN=36197697","DOI":"10.1111\/ajd.13932"},{"key":"5513_CR43","doi-asserted-by":"crossref","unstructured":"Zakine E, Schell B, Battistella M, Vignon-Pennamen MD, Chasset F, Mahevas T, et al (2021) UBA1 Variations in neutrophilic dermatosis skin lesions of patients with VEXAS syndrome. JAMA Dermatol [Internet] 57(11):1349\u201354. https:\/\/authproxy.bma.org.uk\/process\/redirects?url=https:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med20&AN=34495287","DOI":"10.1001\/jamadermatol.2021.3344"},{"issue":"3","key":"5513_CR44","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/bjd.20805","volume":"186","author":"S Georgin-Lavialle","year":"2022","unstructured":"Georgin-Lavialle S, Terrier B, Guedon AF, Heiblig M, Comont T, Lazaro E et al (2022) Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients. Br J Dermatol [Internet] 186(3):564\u2013574. https:\/\/doi.org\/10.1111\/bjd.20805","journal-title":"Br J Dermatol [Internet]"},{"issue":"13","key":"5513_CR45","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1182\/blood.2022016985","volume":"140","author":"MA Ferrada","year":"2022","unstructured":"Ferrada MA, Savic S, Cardona DO, Collins JC, Alessi H, Gutierrez-Rodrigues F et al (2022) Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesis. Blood 140(13):1496\u20131506","journal-title":"Blood"},{"key":"5513_CR46","doi-asserted-by":"publisher","unstructured":"Beck DB, Bodian DL, Shah V, Mirshahi UL, Kim J, Ding Y, et al (47) Genomic ascertainment for UBA1 variants and VEXAS syndrome: a population-based study. medRxiv [Internet]. 2022 Aug 1 [cited 2023 Oct 1];2022.07.27.22277962. https:\/\/doi.org\/10.1101\/2022.07.27.22277962v1","DOI":"10.1101\/2022.07.27.22277962v1"},{"key":"5513_CR47","doi-asserted-by":"crossref","unstructured":"Dehghan N, Marcon KM, Sedlic T, Beck DB, Dutz JP, Chen LYC (2021) Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome: fevers, myalgia, arthralgia, auricular chondritis, and erythema nodosum. The Lancet [Internet]. 2021 Aug 14 [cited 2023 Aug 13];398(10300):621. http:\/\/www.thelancet.com\/article\/S0140673621014306\/fulltext","DOI":"10.1016\/S0140-6736(21)01430-6"},{"issue":"1","key":"5513_CR48","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/ddg.14933","volume":"21","author":"C Collantes-Rodr\u00edguez","year":"2023","unstructured":"Collantes-Rodr\u00edguez C, Jim\u00e9nez-Gallo D, de la Varga- MR, Mora-L\u00f3pez F, Garrastazul-S\u00e1nchez MP, Linares-Barrios M (2023) Vexas syndrome successfully treated with canakinumab. JDDG Journal der Deutschen Dermatologischen Gesellschaft Internet. 21(1):69\u201370. https:\/\/doi.org\/10.1111\/ddg.14933","journal-title":"JDDG Journal der Deutschen Dermatologischen Gesellschaft Internet."},{"key":"5513_CR49","doi-asserted-by":"crossref","unstructured":"Euvrard R, Fournier T, Georgescu D, Bourbon E, Sujobert P, Lega JC, et al (2021) VEXAS syndrome-related AA amyloidosis: a case report. Rheumatology (Oxford) [Internet]. 2021 Jan 1 [cited 2023 Aug 13];61(1):E15\u20136 https:\/\/pubmed.ncbi.nlm.nih.gov\/34498034\/","DOI":"10.1093\/rheumatology\/keab683"},{"key":"5513_CR50","doi-asserted-by":"crossref","unstructured":"Guerrero-Bermudez CA, Cardona-Cardona AF, Ariza-Parra EJ, Arostegui JI, Mensa-Vilaro A, Yague J, et al (2022) Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS syndrome) with prominent supraglottic larynx involvement: a case-based review. Clin Rheumatol [Internet] 41(11):3565\u201372. https:\/\/authproxy.bma.org.uk\/process\/redirects?url=https:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med22&AN=35986821","DOI":"10.1007\/s10067-022-06338-1"},{"key":"5513_CR51","doi-asserted-by":"crossref","unstructured":"Horton RK, Zheng G (2021) A case of VEXAS syndrome with subtle morphologic findings. Blood [Internet] 138(15):1378. https:\/\/authproxy.bma.org.uk\/process\/redirects?url=https:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med20&AN=34647982","DOI":"10.1182\/blood.2021012596"},{"key":"5513_CR52","doi-asserted-by":"crossref","unstructured":"Kunishita Y, Kirino Y, Tsuchida N, Maeda A, Sato Y, Takase-Minegishi K, et al (2022) Case report: tocilizumab treatment for VEXAS syndrome with relapsing polychondritis: a single-center, 1-Year longitudinal observational study In Japan. Front Immunol [Internet] 13:901063. https:\/\/authproxy.bma.org.uk\/process\/redirects?url=https:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med22&AN=35769485","DOI":"10.3389\/fimmu.2022.901063"},{"key":"5513_CR53","doi-asserted-by":"crossref","unstructured":"Lytle A, Bagg A (2021) VEXAS: a vivid new syndrome associated with vacuoles in various hematopoietic cells. Blood [Internet] 137(26):3690. https:\/\/authproxy.bma.org.uk\/process\/redirects?url=https:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med20&AN=34196684","DOI":"10.1182\/blood.2021010714"},{"key":"5513_CR54","doi-asserted-by":"crossref","unstructured":"Neupane K, Jayarangaiah A, Zhang Y, Kumar A (2022) VEXAS syndrome with progression of MDS to MDS\/MPN overlap syndrome. BMJ Case Rep [Internet]. 15(12):22. https:\/\/authproxy.bma.org.uk\/process\/redirects?url=https:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=medl&AN=36549759","DOI":"10.1136\/bcr-2022-251089"},{"key":"5513_CR55","doi-asserted-by":"crossref","unstructured":"Tsuchida N, Kunishita Y, Uchiyama Y, Kirino Y, Enaka M, Yamaguchi Y, et al (2021) Pathogenic UBA1 variants associated with VEXAS syndrome in Japanese patients with relapsing polychondritis. Ann Rheum Dis [Internet] 80(8):1057\u201361. https:\/\/authproxy.bma.org.uk\/process\/redirects?url=https:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med19&AN=33789873","DOI":"10.1136\/annrheumdis-2021-220089"},{"key":"5513_CR56","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead506","author":"BE S\u00e1nchez-Hern\u00e1ndez","year":"2023","unstructured":"S\u00e1nchez-Hern\u00e1ndez BE, Calder\u00f3n-Espinoza I, Mart\u00edn-Nares E (2023) Challenging the paradigm: a case of early-onset VEXAS syndrome. Rheumatology [Internet]. https:\/\/doi.org\/10.1093\/rheumatology\/kead506","journal-title":"Rheumatology [Internet]"},{"key":"5513_CR57","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead472","author":"B Podvin","year":"2023","unstructured":"Podvin B, Cleenewerck N, Nibourel O, Marceau-Renaut A, Roynard P, Preudhomme C et al (2023) Three UBA1 clones for a unique VEXAS syndrome. Rheumatology. https:\/\/doi.org\/10.1093\/rheumatology\/kead472","journal-title":"Rheumatology"},{"key":"5513_CR58","doi-asserted-by":"crossref","unstructured":"Al-Hakim A, Cull A, Topping J, Nadat F, Milek J, Alhefzi R, et al (2023) Recovery of bone marrow function in VEXAS syndrome-potential role for romiplostim. Hemasphere [Internet]. 2023 Aug 26 [cited 2023 Oct 30];7(8):E934. https:\/\/pubmed.ncbi.nlm.nih.gov\/37520777\/","DOI":"10.1097\/HS9.0000000000000934"},{"key":"5513_CR59","doi-asserted-by":"crossref","unstructured":"Kunimoto H, Miura A, Maeda A, Tsuchida N, Uchiyama Y, Kunishita Y, et al (2023) Clinical and genetic features of Japanese cases of MDS associated with VEXAS syndrome. Int J Hematol [Internet]. 2023 Oct 1 [cited 2023 Oct 30];118(4). https:\/\/pubmed.ncbi.nlm.nih.gov\/37062784\/","DOI":"10.1007\/s12185-023-03598-8"},{"key":"5513_CR60","doi-asserted-by":"crossref","unstructured":"Ross C, Elfassy HL, Makhzoum JP (2021) Somatic mutation in UBA1 and ANCA-associated Vasculitis. J Rheumatol [Internet] 1. https:\/\/authproxy.bma.org.uk\/process\/redirects?url=https:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexb&AN=635233348","DOI":"10.3899\/jrheum.210149"},{"key":"5513_CR61","doi-asserted-by":"crossref","unstructured":"Thomas B, Campagne J (2022) Vexas: A new syndrome not always associated with hemopathy. EJHaem [Internet]. 3(1):235. https:\/\/authproxy.bma.org.uk\/process\/redirects?url=https:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=pmnm7&AN=35846195","DOI":"10.1002\/jha2.341"},{"key":"5513_CR62","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead536","author":"H Oka","year":"2023","unstructured":"Oka H, Sumitomo S, Nishikubo M, Yamashita D, Maruoka H, Shiroishi Y et al (2023) VEXAS syndrome with granulomatosis with polyangiitis manifestation: retained in remission using methotrexate and infliximab. Rheumatology. https:\/\/doi.org\/10.1093\/rheumatology\/kead536","journal-title":"Rheumatology"},{"key":"5513_CR63","doi-asserted-by":"crossref","unstructured":"Fan BE, Cao L, Gallardo CA, Lee SMS, Koh LW, Goh LL, et al (2021) Myeloid and lymphoid vacuolation in VEXAS syndrome. Am J Hematol [Internet]. 96(8):1056\u20137. https:\/\/authproxy.bma.org.uk\/process\/redirects?url=https:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med19&AN=33460492","DOI":"10.1002\/ajh.26098"},{"key":"5513_CR64","doi-asserted-by":"crossref","unstructured":"Matsuki Y, Kawai R, Suyama T, Katagiri K, Kanazawa N, Inaba Y (2022) A case of VEXAS syndrome with myositis possibly associated with macrophage activation syndrome. J Dermatol [Internet]. 49(12):e441\u20133. https:\/\/authproxy.bma.org.uk\/process\/redirects?url=https:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med22&AN=35924490","DOI":"10.1111\/1346-8138.16535"},{"key":"5513_CR65","doi-asserted-by":"crossref","unstructured":"Staels F, Betrains A, Woei AJF, Boeckx N, Beckers M, Bervoets A, et al (2021) Case Report: VEXAS syndrome: from mild symptoms to life-threatening macrophage activation syndrome. Front Immunol [Internet]. 2021;12:678927. https:\/\/authproxy.bma.org.uk\/process\/redirects?url=https:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med20&AN=34046042","DOI":"10.3389\/fimmu.2021.678927"},{"key":"5513_CR66","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead240","author":"Z Boyadzhieva","year":"2023","unstructured":"Boyadzhieva Z, Ruffer N, K\u00f6tter I, Krusche M (2023) How to treat VEXAS syndrome: a systematic review on effectiveness and safety of current treatment strategies. Rheumatology. https:\/\/doi.org\/10.1093\/rheumatology\/kead240","journal-title":"Rheumatology"},{"key":"5513_CR67","doi-asserted-by":"crossref","unstructured":"Gurnari C, McLornan DP (2022) Update on VEXAS and role of allogeneic bone marrow transplant: considerations on behalf of the Chronic Malignancies Working Party of the EBMT. Bone Marrow Transplant 2022 57:11 [Internet]. 2022 Aug 8 [cited 2023 Aug 6];57(11):1642\u20138. https:\/\/www.nature.com\/articles\/s41409-022-01774-8","DOI":"10.1038\/s41409-022-01774-8"},{"key":"5513_CR68","doi-asserted-by":"crossref","unstructured":"Hage-Sleiman M, Lalevee S, Guermouche H, Favale F, Chaquin M, Battistella M, et al (2021) Dominance of an UBA1 mutant clone over a CALR mutant clone: from essential thrombocytemia to VEXAS. Haematologica [Internet]. 2021;106(12):3245\u20138. https:\/\/authproxy.bma.org.uk\/process\/redirects?url=https:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med20&AN=34320791","DOI":"10.3324\/haematol.2021.279418"},{"issue":"8","key":"5513_CR69","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1182\/blood.2022016642","volume":"140","author":"M Heiblig","year":"2022","unstructured":"Heiblig M, Ferrada MA, Koster MT, Barba T, Gerfaud-Valentin M, M\u00e9kinian A et al (2022) Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study. Blood 140(8):927\u2013931","journal-title":"Blood"},{"key":"5513_CR70","unstructured":"Argobi Y (2022) VEXAS syndrome with cutaneous nodules. Dermatol Reports [Internet]. 2022;14(2):9414. https:\/\/authproxy.bma.org.uk\/process\/redirects?url=https:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=pmnm7&AN=35795842"},{"key":"5513_CR71","doi-asserted-by":"crossref","unstructured":"Austestad J, Madland TM, Sandnes M, Haslerud TM, Benneche A, Reikvam H (2023) VEXAS syndrome in a patient with myeloproliferative neoplasia. Case Rep Hematol [Internet]. 2023 Feb 25 [cited 2023 Aug 13];2023:1\u20137. https:\/\/pubmed.ncbi.nlm.nih.gov\/36879894\/","DOI":"10.1155\/2023\/6551544"},{"key":"5513_CR72","doi-asserted-by":"crossref","unstructured":"Balu B, Ding Y, Junkins-Hopkins JM (2023) VEXAS syndrome: diagnostic clues for dermatologists. Int J Dermatol [Internet]. 2023 [cited 2023 Aug 13]; https:\/\/pubmed.ncbi.nlm.nih.gov\/36841896\/","DOI":"10.1111\/ijd.16627"},{"issue":"11","key":"5513_CR73","doi-asserted-by":"publisher","first-page":"e402","DOI":"10.1093\/rheumatology\/keab392","volume":"60","author":"T Barba","year":"2021","unstructured":"Barba T, Jamilloux Y, Durel CA, Bourbon E, Mestrallet F, Sujobert P et al (2021) VEXAS syndrome in a woman. Rheumatology [Internet] 60(11):e402\u2013e403. https:\/\/doi.org\/10.1093\/rheumatology\/keab392","journal-title":"Rheumatology [Internet]"},{"key":"5513_CR74","doi-asserted-by":"crossref","unstructured":"Battipaglia G, Vincenzi A, Falconi G, Fiore A, D\u2019Agostino F, Iannotta R, et al (2023) New scenarios in Vacuoles, E1 enzyme, X linked, Autoinflammatory, Somatic (VEXAS) syndrome: Evolution from myelodysplastic syndrome to acute myeloid leukemia. Curr Res Transl Med [Internet]. 2023 Apr 1 [cited 2023 Oct 30];71(2). https:\/\/pubmed.ncbi.nlm.nih.gov\/36905702\/","DOI":"10.1016\/j.retram.2023.103386"},{"key":"5513_CR75","unstructured":"Beecher M, Tong J, Halliday L, Hissaria P, Selva D (2022) Recurrent dacryoadenitis associated with VEXAS syndrome. Clin Exp Ophthalmol [Internet]. 50:934. https:\/\/authproxy.bma.org.uk\/process\/redirects?url=https:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexa&AN=639618442"},{"key":"5513_CR76","doi-asserted-by":"crossref","unstructured":"Belicard F, Belhomme N, Bouzy S, Saillard C, Nedelec F, Mear JB, et al (2023) Vacuoles, E1 enzyme, X-linked, autoinflammatory, and somatic syndrome in the intensive care unit: a case report. J Med Case Rep [Internet]. 2023 Dec 1 [cited 2023 Oct 30];17(1). https:\/\/pubmed.ncbi.nlm.nih.gov\/37480098\/","DOI":"10.1186\/s13256-023-04034-5"},{"key":"5513_CR77","doi-asserted-by":"crossref","unstructured":"Campochiaro C, Tomelleri A, Cavalli G, De Luca G, Grassini G, Cangi MG, et al (2022) Successful use of cyclosporin A and interleukin-1 blocker combination therapy in VEXAS syndrome: a single-center case series. Arthritis Rheumatol [Internet]. 2022 Jul 1 [cited 2023 Aug 13];74(7):1302\u20133. https:\/\/pubmed.ncbi.nlm.nih.gov\/35212178\/","DOI":"10.1002\/art.42101"},{"key":"5513_CR78","unstructured":"Cifersk\u00e1 H, Gregov\u00e1 M, Klein M, \u0160enolt L, Maaloufov\u00e1 JS, Pavelka K, et al (2022) VEXAS syndrome: a report of three cases. Clin Exp Rheumatol [Internet]. 2022 Jul 1 [cited 2023 Aug 13];40(7):1449. https:\/\/pubmed.ncbi.nlm.nih.gov\/35238760\/"},{"key":"5513_CR79","unstructured":"Fabian L, Luca S, Adela S, Britta M (2021) Genetic double strike: VEXAS and TET2 positive myelodysplastic syndrome in a patient with long-standing refractory autoinflammatory disease. Case Report. Swiss Med Wkly [Internet]. 2021;151:5S. https:\/\/authproxy.bma.org.uk\/process\/redirects?url=https:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed22&AN=636023872"},{"key":"5513_CR80","doi-asserted-by":"crossref","unstructured":"Fagart A, Quemeneur T, Collet G, Demailly F, Rousselin C (2023) A \u201cLeopard Man\u201d Aspect on 18 F-FDG PET\/CT Revealing a VEXAS Syndrome. Clin Nucl Med [Internet]. 48(1):e33\u20134. https:\/\/authproxy.bma.org.uk\/process\/redirects?url=https:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med22&AN=36252945","DOI":"10.1097\/RLU.0000000000004443"},{"key":"5513_CR81","doi-asserted-by":"crossref","unstructured":"Fahmy LM, Schreidah CM, Lapolla BA, Magro CM, Geskin LJ (2023) VEXAS syndrome presenting as refractory cutaneous Kikuchi disease-like inflammatory pattern responding to tofacitinib. JAAD Case Rep [Internet]. 2023 Aug 1 [cited 2023 Oct 30];38:136\u201340. https:\/\/pubmed.ncbi.nlm.nih.gov\/37521198\/","DOI":"10.1016\/j.jdcr.2023.06.021"},{"key":"5513_CR82","doi-asserted-by":"crossref","unstructured":"Fanlo P, Rom\u00e1n ML de S, Fonollosa A, Ilarramendi J, Heras H, Grayson P (2023) Episcleritis and periorbital edema secondary to VEXAS syndrome. Arch Soc Esp Oftalmol [Internet]. 2023 Oct [cited 2023 Oct 30];98(10). https:\/\/pubmed.ncbi.nlm.nih.gov\/37595794\/","DOI":"10.1016\/j.oftale.2023.07.004"},{"key":"5513_CR83","doi-asserted-by":"crossref","unstructured":"Fenu EM, Bagg A (2023) VEXAS\u2019d by lymphadenopathy: an unusual case of extramedullary hematopoiesis. Blood [Internet]. 2023 Jun 1 [cited 2023 Oct 30];141(22):2784. https:\/\/pubmed.ncbi.nlm.nih.gov\/37261849\/","DOI":"10.1182\/blood.2023020012"},{"key":"5513_CR84","doi-asserted-by":"crossref","unstructured":"Goyal A, Narayanan D, Wong W, Laga AC, Connell NT, Ritter SY, et al (2022) Tocilizumab for treatment of cutaneous and systemic manifestations of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome without myelodysplastic syndrome. JAAD Case Rep [Internet]. 23:15\u20139. https:\/\/authproxy.bma.org.uk\/process\/redirects?url=https:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=pmnm7&AN=35391910","DOI":"10.1016\/j.jdcr.2022.02.022"},{"key":"5513_CR85","doi-asserted-by":"crossref","unstructured":"Grambow-Velilla J, Braun T, Pop G, Louzoun A, Soussan M (2023) Aortitis PET Imaging in VEXAS syndrome: a case report. Clin Nucl Med [Internet]. 48(2):e67\u20138. https:\/\/authproxy.bma.org.uk\/process\/redirects?url=https:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=medl&AN=36607374","DOI":"10.1097\/RLU.0000000000004506"},{"key":"5513_CR86","doi-asserted-by":"crossref","unstructured":"Grosse A, Salehi T, Callary M, Hecker JR, Hissaria P (2022) VEXAS syndrome causing fever of unknown origin. Med J Australia [Internet]. 217(3):129\u201330. https:\/\/authproxy.bma.org.uk\/process\/redirects?url=https:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med22&AN=35793067","DOI":"10.5694\/mja2.51646"},{"key":"5513_CR87","unstructured":"Haines P, Pullarkat S, Said J (2023) VEXAS syndrome: Vacuoles in myeloid, erythroid, and lymphoid lineages. Int J Lab Hematol [Internet]. 2023 [cited 2023 Oct 30]; https:\/\/pubmed.ncbi.nlm.nih.gov\/37674280\/"},{"key":"5513_CR88","doi-asserted-by":"crossref","unstructured":"Himmelmann A, Brucker R (2021) The VEXAS Syndrome: uncontrolled inflammation and macrocytic anaemia in a 77-year-old male patient. Eur J Case Rep Intern Med [Internet]. 8(4):002484. https:\/\/authproxy.bma.org.uk\/process\/redirects?url=https:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=pmnm6&AN=33987129","DOI":"10.12890\/2021_002484"},{"key":"5513_CR89","doi-asserted-by":"crossref","unstructured":"Huang H, Zhang W, Cai W, Liu J, Wang H, Qin T, et al (2021) VEXAS syndrome in myelodysplastic syndrome with autoimmune disorder. Exp Hematol Oncol [Internet]. 10(1):23. https:\/\/authproxy.bma.org.uk\/process\/redirects?url=https:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=pmnm6&AN=33741056","DOI":"10.1186\/s40164-021-00217-2"},{"key":"5513_CR90","doi-asserted-by":"crossref","unstructured":"Islam S, Cullen T, Sumpton D, Damodaran A, Heath D, Bosco A, et al (2022) VEXAS syndrome: lessons learnt from an early Australian case series. Intern Med J [Internet]. 52(4):658\u201362. https:\/\/authproxy.bma.org.uk\/process\/redirects?url=https:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med22&AN=35419965","DOI":"10.1111\/imj.15742"},{"key":"5513_CR91","doi-asserted-by":"crossref","unstructured":"Itagane M, Teruya H, Kato T, Tsuchida N, Maeda A, Kirino Y, et al (2022) Clinical images: VEXAS syndrome presenting as treatment-refractory polyarteritis nodosa. Arthritis Rheumatol [Internet]. 74(11):1863\u20134. https:\/\/authproxy.bma.org.uk\/process\/redirects?url=https:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med22&AN=35696330","DOI":"10.1002\/art.42257"},{"key":"5513_CR92","doi-asserted-by":"crossref","unstructured":"Kao RL, Jacobsen AA, Billington Jr. CJ, Yohe SL, Beckman AK, Vercellotti GM, et al (2022) A case of VEXAS syndrome associated with EBV-associated hemophagocytic lymphohistiocytosis. Blood Cells Mol Dis [Internet]. 93:102636. https:\/\/authproxy.bma.org.uk\/process\/redirects?url=https:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med21&AN=34864445","DOI":"10.1016\/j.bcmd.2021.102636"},{"key":"5513_CR93","doi-asserted-by":"crossref","unstructured":"Kataoka A, Mizumoto C, K, a J, Iwasaki M, Sakurada M, et al (2023) Successful azacitidine therapy for myelodysplastic syndrome associated with VEXAS syndrome. Int J Hematol [Internet]. 14:14. https:\/\/authproxy.bma.org.uk\/process\/redirects?url=https:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=medp&AN=36641501","DOI":"10.1007\/s12185-023-03532-y"},{"key":"5513_CR94","doi-asserted-by":"crossref","unstructured":"Li P, Venkatachalam S, Ospina Cordona D, Wilson L, Kovacsovics T, Moser KA, et al (2022) A clinical, histopathological, and molecular study of two cases of VEXAS syndrome without a definitive myeloid neoplasm. Blood Adv [Internet]. 6(2):405\u20139. Available from: https:\/\/authproxy.bma.org.uk\/process\/redirects?url=https:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med21&AN=34649277","DOI":"10.1182\/bloodadvances.2021005243"},{"key":"5513_CR95","doi-asserted-by":"crossref","unstructured":"Lohaus N, Schaab J, Schaer D, Balabanov S, Huellner MW (2023) VEXAS syndrome with tracheal involvement but absence of vasculitis in FDG PET\/CT. Clin Nucl Med [Internet]. 2023 Sep 1 [cited 2023 Oct 30];48(9):E444\u20135. https:\/\/pubmed.ncbi.nlm.nih.gov\/37418279\/","DOI":"10.1097\/RLU.0000000000004770"},{"key":"5513_CR96","unstructured":"Lokhande A, Jarmale S, Vaishnav YJ, Schaefer J (2023) An Orbital Manifestation of VEXAS Syndrome. Ophthalmic Plast Reconstr Surg [Internet]. 2023 Jul 4 [cited 2023 Oct 30]; https:\/\/pubmed.ncbi.nlm.nih.gov\/37405738\/"},{"key":"5513_CR97","doi-asserted-by":"crossref","unstructured":"Matsubara A, Tsuchida N, Sakurai M, Maeda A, Uchiyama Y, Sasaki K, et al (2022) A case of VEXAS syndrome with Sweet\u2019s disease and pulmonary involvement. Journal of Dermatology [Internet]. 49(5):e177\u20138. Available from: https:\/\/authproxy.bma.org.uk\/process\/redirects?url=https:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med21&AN=35166394","DOI":"10.1111\/1346-8138.16311"},{"key":"5513_CR98","doi-asserted-by":"crossref","unstructured":"Matsumoto H, Fujita Y, Fukatsu M, Ikezoe T, Yokose K, Asano T, et al (2022) Case Report: Coexistence of Multiple Myeloma and Auricular Chondritis in VEXAS Syndrome. Front Immunol [Internet]. 13:897722. https:\/\/authproxy.bma.org.uk\/process\/redirects?url=https:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med22&AN=35757758","DOI":"10.3389\/fimmu.2022.897722"},{"key":"5513_CR99","unstructured":"Miyoshi Y, Kise T, Morita K, Okada H, Imadome KI, Tsuchida N, et al. Long-term remission of VEXAS syndrome achieved by a single course of CHOP therapy: a case report. Mod Rheumatol Case Rep [Internet]. 2023 Jul 24 [cited 2023 Oct 30]. https:\/\/pubmed.ncbi.nlm.nih.gov\/37548220\/"},{"key":"5513_CR100","doi-asserted-by":"crossref","unstructured":"Mohammed TO, Alavi A, Aghazadeh N, Koster MJ, Olteanu H, Mangaonkar AA, et al (2022) Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome: a presentation of two cases with dermatologic findings. Int J Dermatol [Internet]. 1:01. https:\/\/authproxy.bma.org.uk\/process\/redirects?url=https:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=medp&AN=35230710","DOI":"10.1111\/ijd.16132"},{"issue":"1","key":"5513_CR101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12348-023-00362-1","volume":"13","author":"K Myint","year":"2023","unstructured":"Myint K, Patrao N, Vonica O, Vahdani K (2023) Recurrent superior orbital fissure syndrome associated with VEXAS syndrome. J Ophthalmic Inflamm Infect [Internet] 13(1):1\u20135. https:\/\/doi.org\/10.1186\/s12348-023-00362-1","journal-title":"J Ophthalmic Inflamm Infect [Internet]"},{"key":"5513_CR102","doi-asserted-by":"crossref","unstructured":"Rieu JB, El Kassir A, Largeaud L, Dion J, Comont T, Mansat-De Mas V (2021) Characteristic vacuolisation of granulocytic and erythroid precursors associated with VEXAS syndrome. Br J Haematol [Internet]. 194(1):8. Available from: https:\/\/authproxy.bma.org.uk\/process\/redirects?url=https:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med19&AN=33651376","DOI":"10.1111\/bjh.17381"},{"key":"5513_CR103","doi-asserted-by":"crossref","unstructured":"Robert M, Berleur M, Gaudemer A, Crow YJ, Fr\u00e9mond ML, Sacr\u00e9 K (2023) VEXAS syndrome: expanding the clinical and molecular spectrum. Jt Bone Spine [Internet]. 2023 May 1 [cited 2023 Oct 30];90(3). https:\/\/pubmed.ncbi.nlm.nih.gov\/36690065\/","DOI":"10.1016\/j.jbspin.2023.105531"},{"key":"5513_CR104","doi-asserted-by":"crossref","unstructured":"Sall\u00e9s M, Fust\u00e0 X, Lidia C, Esquius M, M\u00ednguez S (2023) Systemic lupus erythematosus in the elderly finally diagnosed with VEXAS syndrome. Clin Exp Rheumatol [Internet] 2023 May 26 [cited 2023 Oct 30]. https:\/\/pubmed.ncbi.nlm.nih.gov\/37470230\/","DOI":"10.55563\/clinexprheumatol\/fde7s1"},{"key":"5513_CR105","doi-asserted-by":"crossref","unstructured":"Shaukat F, Hart M, Burns T, Bansal P (2022) UBA1 and DNMT3A mutations in VEXAS syndrome. A case report and literature review. Mod Rheumatol Case Rep [Internet] 6(1):134\u20139. https:\/\/authproxy.bma.org.uk\/process\/redirects?url=https:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med21&AN=34480172","DOI":"10.1093\/mrcr\/rxab021"},{"key":"5513_CR106","doi-asserted-by":"crossref","unstructured":"Takahashi N, Takeichi T, Nishida T, Sato J, Takahashi Y, Yamamura M, et al (2021) Extensive multiple organ involvement in VEXAS syndrome. Arthritis Rheumatol [Internet] 73(10):1896\u20137. https:\/\/authproxy.bma.org.uk\/process\/redirects?url=https:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med20&AN=33881233","DOI":"10.1002\/art.41775"},{"key":"5513_CR107","doi-asserted-by":"crossref","unstructured":"Tosato F, Pelloso M, Zuin J, Basso D (2023) Peripheral blood cells vacuoles in VEXAS syndrome. Am J Hematol [Internet] 98(10):1663\u20134. https:\/\/pubmed.ncbi.nlm.nih.gov\/37073682\/","DOI":"10.1002\/ajh.26931"},{"key":"5513_CR108","doi-asserted-by":"crossref","unstructured":"Tozaki N, Tawada C, Niwa H, Mizutani Y, Shu E, Kawase A, et al (2022) A case of VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) with decreased oxidative stress levels after oral prednisone and tocilizumab treatment. Front Med (Lausanne) [Internet] 9:1046820. https:\/\/authproxy.bma.org.uk\/process\/redirects?url=https:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=pmnm&AN=36544501","DOI":"10.3389\/fmed.2022.1046820"},{"issue":"9","key":"5513_CR109","doi-asserted-by":"publisher","first-page":"e271","DOI":"10.1093\/rheumatology\/kead076","volume":"62","author":"L Valor-M\u00e9ndez","year":"2023","unstructured":"Valor-M\u00e9ndez L, Sticherling M, Zeschick M, Atreya R, Schmidt FD, Waldfahrer F et al (2023) VEXAS syndrome mimicking lupus-like disease. Rheumatology [Internet] 62(9):e271\u2013e272. https:\/\/doi.org\/10.1093\/rheumatology\/kead076","journal-title":"Rheumatology [Internet]"},{"key":"5513_CR110","doi-asserted-by":"crossref","unstructured":"Varadarajan A, Verghese R, Tirlangi PK, Dass J, Soneja M, Seth T (2022) VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic). Qjm [Internet]. 21:21. https:\/\/authproxy.bma.org.uk\/process\/redirects?url=https:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=medp&AN=36409014","DOI":"10.1093\/qjmed\/hcac259"},{"issue":"1","key":"5513_CR111","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41927-023-00343-w","volume":"7","author":"KT Vu","year":"2023","unstructured":"Vu KT, Wolfe RM, Lambird JE, Maracaja DLV (2023) A case of VEXAS syndrome presenting with unusual bone marrow granulomas: a diagnostic dilemma. BMC Rheumatol [Internet] 7(1):1\u20136. https:\/\/doi.org\/10.1186\/s41927-023-00343-w","journal-title":"BMC Rheumatol [Internet]"},{"key":"5513_CR112","doi-asserted-by":"crossref","unstructured":"Yamaguchi H, Kobayashi D, Nakamura G, Aida R, Horii Y, Okamoto T, et al (2023) Acute heart failure due to left common iliac arteriovenous fistula: a case of VEXAS syndrome. Mod Rheumatol Case Rep [Internet] 7(1):327\u201333. https:\/\/authproxy.bma.org.uk\/process\/redirects?url=https:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=medl&AN=36264203","DOI":"10.1093\/mrcr\/rxac082"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-023-05513-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-023-05513-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-023-05513-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T09:05:53Z","timestamp":1718355953000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-023-05513-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,21]]},"references-count":112,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["5513"],"URL":"https:\/\/doi.org\/10.1007\/s00296-023-05513-0","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,21]]},"assertion":[{"value":"19 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors KK, MD, JA, NM and AN declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}